Proteros Elects New Supervisory Board Member
News Feb 20, 2014
Prof. Pâques is presently CEO and Chairman of the Corporate Executive Board of Grünenthal, an international research-based pharmaceutical company headquartered in Aachen, Germany. Prior to his more than 20 years at Grünenthal, he worked as the Head of Research at Behringwerke AG, in Germany. Prof. Pâques received a doctorate in Chemistry from the Université Catholique de Louvain.
“We are delighted to have Eric-Paul joining our board” commented Dave Lemus, Chairman of the Supervisory Board of Proteros. “His extensive experience in the pharmaceutical industry will prove invaluable to Proteros as the company accelerates its transition to the next phase of its development.”
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.READ MORE